There is a desperate need for randomised trials on the use of medical cannabis in drug-resistant epilepsy in adults, an expert has told the ANZAN 2018 conference in Darwin. Speaking during a symposium dedicated to medical cannabis Professor Terry O’Brien, Director of Neurology at Alfred Health in Melbourne, noted that much of the hype around ...
Evidence lacking, cost high for medical cannabis in adult epilepsy
By Nicola Garrett
31 May 2018